Compare AEE & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AEE | DXCM |
|---|---|---|
| Founded | 1901 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.5B | 25.9B |
| IPO Year | N/A | 2005 |
| Metric | AEE | DXCM |
|---|---|---|
| Price | $98.27 | $66.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 21 |
| Target Price | ★ $109.91 | $87.90 |
| AVG Volume (30 Days) | 1.7M | ★ 5.3M |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | ★ 2.92% | N/A |
| EPS Growth | ★ 22.35 | 7.75 |
| EPS | ★ 5.21 | 1.80 |
| Revenue | ★ $8,635,000,000.00 | $4,515,900,000.00 |
| Revenue This Year | $14.17 | $17.41 |
| Revenue Next Year | $5.69 | $12.78 |
| P/E Ratio | ★ $18.68 | $37.27 |
| Revenue Growth | ★ 23.25 | 14.21 |
| 52 Week Low | $86.40 | $54.11 |
| 52 Week High | $106.73 | $93.25 |
| Indicator | AEE | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 34.75 | 57.28 |
| Support Level | $96.57 | $64.00 |
| Resistance Level | $106.61 | $69.77 |
| Average True Range (ATR) | 1.54 | 1.88 |
| MACD | -0.46 | 0.44 |
| Stochastic Oscillator | 14.15 | 61.68 |
Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas through the company's two main subsidiaries, Ameren Missouri and Ameren Illinois. It serves 2.5 million electricity customers and 800,000 natural gas customers across its two service territories.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.